Tuesday, 15th November Joint 2016 COSA and ANZBCTG Annual Scientific Meeting

7:00AM - 6:00PM
Tuesday, 15th November
Foyer
7:00AM - 8:15AM
Tuesday, 15th November
Room 5
Sponsored by:
Clinical Oncology Society of Australia

Content: In this interactive breakfast session invited international speaker, Professor Melinda Irwin from Yale School of Public Health, will discuss current and future opportunities and challenges in physical activity and cancer research and clinical care. Prof Irwin is a prominent leader in the field of physical activity and cancer risk and mortality. Her research over the past 15 years has focused on randomized trials of exercise and weight loss on biological markers, treatment side effects and quality of life in cancer patients and survivors.

Speaker: Melinda Irwin

7:00AM - 8:15AM
Tuesday, 15th November
Room 6
Sponsored by:

Content: This breakfast symposium will provide attendees with insights into breakthrough cancer pain: the definition of breakthrough cancer pain, how its management is evolving and what this means for the doctor, the palliative care team and the patient. Professor Richard Chye, Palliative Care specialist at St Vincent’s Hospital, Sydney, will share his knowledge relating to the management of breakthrough cancer pain. A patient will also discuss the impact of effective breakthrough cancer pain management on his quality of life. There will be time for questions and discussion.

Speaker: Professor Ricahrd Chye Director, Sacred Heart Supportive & Palliative Care St Vincent’s Hospital Sydney, NSW

7:00AM - 8:15AM
Tuesday, 15th November
Room 7
Chair: Fran Boyle
Sponsored by:

This breakfast symposium will give attendees insights into the practical aspects of proactively managing everolimus-induced stomatitis In the recently reported SWISH clinical trial, prophylactic use of a dexamethasone solution as a mouthwash four times daily for the first 8 weeks of treatment significantly reduced the incidence of everolimus-induced stomatitis1. In the light of the SWISH trial outcome, this session will discuss the practicalities of managing everolimus-associated stomatitis in Australia with two real-world perspectives. Dr Lina Pugliano will review the SWISH trial data and then discuss her experiences and give her insights into prophylactically managing everolimus-related stomatitis. Pharmacist Obaid Fazli will outline different approaches to supplying everolimus patients with steroidal mouthwash that are currently being practised in Australia, highlighting the practical benefits and limits of these.

1Rugo, HS, J Clin Oncol 34, 2016 (suppl; abstr 525)

Speakers: 
Dr Lina Pugliano, Medical Oncologist Northern Cancer Institute (NCI) St Leonards, Sydney, NSW 
SWISH trial recap: using prophylactic steroidal mouthwash to control everolimus-associated stomatitis 

Obaid Fazli, Assistant Deputy Director and Senior Oncology Pharmacist, Monash Health-Moorabbin Pharmacy Department, Melbourne, Victoria 
Putting SWISH into practice: adapting SWISH to the Australian setting 

8:30AM - 9:00AM
Tuesday, 15th November
Arena 1B
Chair: Mei Krishnasamy

Welcome by COSA President

Welcome to Country by local Indigenous group

Official opening by His Excellency the Honorable Paul de Jersey AC, Governor of Queensland

10:30AM - 11:00AM
Tuesday, 15th November
Halls 1 & 2
Sponsored by:
12:30PM - 1:30PM
Tuesday, 15th November
Halls 1 & 2
Sponsored by:
12:30PM - 1:30PM
Tuesday, 15th November
Room 5
12:30PM - 1:30PM
Tuesday, 15th November
Room 6
12:30PM - 1:30PM
Tuesday, 15th November
Room 7
12:30PM - 1:30PM
Tuesday, 15th November
Room 8
1:30PM - 3:00PM
Tuesday, 15th November
Arena 1B
Chair: Michael Powell
Sponsored by:

 

 

3:00PM - 4:00PM
Tuesday, 15th November
Halls 1 & 2
3:00PM - 4:00PM
Tuesday, 15th November
Halls 1 & 2
4:00PM - 5:30PM
Tuesday, 15th November
Arena 1B
Chair: Bogda Koczwara

5.00 PM  Panel discussion with case studies

5:30PM - 7:00PM
Tuesday, 15th November
Halls 1 & 2
Sponsored by:
7:00PM - 10:00PM
Tuesday, 15th November
Room 5
Chair: Paul Glare
Sponsored by:

Speaker: Dr Tim Grice

"Are all opioids created equal?… Join us to learn more about Palexia and its role in the treatment of Chronic Cancer Pain"